Zenith TX2 Pro-Form G53459Recalls & reported problems
William Cook Europe ApS · Zenith TX2,TAA Endovascular Graft with Pro-Form, Proximal Extension · Class 3 · Implant
All models of Zenith TX2 Pro-Form (15)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10827002534596), received between Mar 17, 2017 and Mar 17, 2017 — classified as 1 injury.
The most frequently reported specific device problem is “Leak/Splash” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Leak/Splash1
Patient problems
- No Code Available1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMar 17, 2017Leak/Splash; Leak/Splash
DESCRIPTION OF EVENT ACCORDING TO STUDY: ON (B)(6) 2012, THE PATIENT RECEIVED ONE TBE-38-77-PF-US (LOT # E2675237). THERE WERE NO DIFFICULTIES DEPLOYING THE DEVICE. A MOLDING BALLOON WAS USED WITHOUT DIFFICULTY. NO PATIENT-RELATED ADVERSE EVENTS WERE OBSERVED DURING THE PROCEDURE. PER SITE, THE DEVICE WAS PATENT WITH NO KINK OR ENDOLEAK ON THE COMPLETION ANGIOGRAM. THE ANALYSIS CONCURRED WITH THE SITE¿S ASSESSMENT. THE PATIENT WAS DISCHARGED FROM THE HOSPITAL ON (B)(6) 2012 (SIX DAYS POST-PROCEDURE). PER ANALYSIS, ALL FOLLOW-UP IMAGING INDICATED NO ISSUES, ALTHOUGH THE ANNUAL CT SCANS AT 2 YEARS AND 3 YEARS POST-IMPLANT WERE NON-CONTRAST, AND THE 4-YEAR FOLLOW-UP CT SCAN WAS NOT DONE. THE ANEURYSM DIAMETER DECREASED FROM 5.76 CM AT ONE MONTH POST-IMPLANT TO 5.3 CM AT 5 YEARS. ON (B)(6) 2017: CT SCAN (1860 DAYS POST-PROCEDURE): PER INVESTIGATIVE SITE: GRAFT PATENT, INTACT WITH NO MIGRATION. AN ENDOLEAK OF UNKNOWN TYPE WAS NOTED. MAXIMUM ANEURYSM DIAMETER = 4.5 CM. PATIENT OUTCOME: NO ADVERSE EVENTS RELATED TO THE STUDY PROCEDURE OR THE DEVICE, AND NO SECONDARY INTERVENTIONS HAVE BEEN REPORTED FOR THIS PATIENT. THE PATIENT EXITED THE CLINICAL STUDY ON (B)(6) 2017.
Patient problems: No Code Available
MAUDE report 6412450 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page